Retatrutide is a synthetic triple-receptor agonist peptide designed to engage GLP-1, GIP, and glucagon receptors in experimental systems
It does not recommend, prescribe, or determine which medications a customer should use
Clinical trials show Mounjaro produced up to 22.5% weight loss, compared with Wegovy's 15% average, though individual responses vary significantly, regardless of which medication shows higher efficacy in controlled studies
If you see a mismatch between claims and actual performance, treat the official rating with caution
Provide a variety of benefits such as lowering blood pressure, helping you take on and recover from the toughest physical activity, boosting the immune system, promoting anti-aging, preserving brain S Book Now Kenalog shot (nondrowsy)
However, this is expected to change in the second quarter of this year when Medicare plans to begin covering Lillys and Novos GLP-1 obesity medications